Our Early Adopter Program offers researchers the opportunity to join us in evaluating and shaping a new, advanced immunofluorescence solution.
Selected participants receive early, complimentary access to the technology and collaborate directly with our development team. By sharing real-world data and feedback, participants help refine the solution, gain recognition for their work, and contribute to the advancement of next-generation research tools.
The exclusive Early Adopter Program has ended on 28.02.2026